A viable organ engineering pipeline requires the mass production of hundreds of billions of cells, tailorable and programmable cellular composition, and technologies to assemble these cells with perfusable vascular networks to support cell viability. Dr. Mark Skylar-Scott's lab is developing integrative technologies, including wetware, hardware, and software, to address cardiac tissue engineering at whole-organ scale.
Home Department: undeclared
Mentor: Tracey McLaughlin (Medicine - Endocrinology)
Home Department: Radiation Oncology
Faculty Advisor: Edward Graves
Talk Title: CD8+ T cells Prevent Circulating Tumor Cell Recruitment After Radiation
Event: The 15th International Tumor Microenvironment Workshop
Supported by The Matthew Frank Family
Awarded in 2014
Talk Title: Category cohesion and distinctiveness in human visual cortex favor basic level representations
Event: Society for Neuroscience Annual Meeting 2014
Dr. Marissa Reitsma is an Assistant Professor of Health Policy at Stanford University School of Medicine. She obtained her PhD in Health Policy at Stanford in 2024, during which time she was a Knight-Hennessy Scholar, Stanford Data Science Scholar, and NSF Graduate Research Fellow. Previously, she worked on the Global Burden of Disease Study at the Institute for Health Metrics and Evaluation. Dr.
